Our Partners











General Criteria

Funds available for the Canadian Hemophilia Society – Novo Nordisk Canada Psychosocial Research Program


The Canadian Hemophilia Society – Novo Nordisk Canada Psychosocial Research Program was created to engage professionals/graduate students from the allied health disciplines (ie. Nursing, Physiotherapy & Social Work) in research activities addressed to understanding the psychosocial impact of hemophilia and other inherited bleeding disorders and to improve the quality of life of persons and families whose lives are affected by these disorders.

Eligibility


A candidate must be a Canadian citizen or permanent resident.

To be eligible the applicant must be a Social Worker, Nurse, or Physiotherapist with professional experience in a hemophilia treatment centre or other comparable settings in which care has been provided to people with hemophilia and other inherited bleeding disorders or persons interested in the field of inherited bleeding disorders. Professionals who have appointments in universities and who can dedicate time to research are encouraged to apply. Students must be in a PhD program in one of the allied health disciplines. Professional experience in a hemophilia treatment centre is desirable but not required.
 
The proposed research must have relevance to current practice in bleeding disorders care and may incorporate a broad spectrum of quantitative and qualitative research methods addressing professional practice with individuals, families, groups and communities, organizational issues, public health, and education.

It is expected that the focus will: (1) promote the integration of psychosocial care with biomedical components of comprehensive care; 2) promote delivery of quality services to patients and families; 3) contributed to the literature on the psychosocial impact of bleeding disorders; (4) demonstrate nursing, physiotherapy or social work outcomes of the research or clinical project.

Interest areas and methodologies might include: impacts of social work/clinical practice on evolving chronic illness and/or disability care modalities; psychosocial  and mental health issues for those affected with bleeding disorders/HIV/HCV; education and vocational issues; increased understanding of issues raised in the HERO (Hemophilia Experiences Results Opportunities) research; media projects and/or learning tools for patient/professional development and evaluation; participatory action, applied and operational research initiatives; interpersonal, gender, sexuality, cultural diversity, workplace, stigma and poverty issues.

Multidisciplinary Collaboration:


Collaboration with multidisciplinary care providers and/or between two or more hemophilia centres is accepted and encouraged. Collaboration efforts may include, for example, nursing, social work, physical therapy and genetics. It thus may be possible for a hemophilia centre team to jointly submit a cooperative research project. Additionally, inter-regional applications will be considered.
 
Grantees must devote full or part time to the research program during the tenure of the Grant as per their proposal which the CHS will have accepted.

Stipend / Duration of Support


The primary intent of this program is to offer one or two $20,000 research grants, to a maximum of $40,000 for one year.

Depending upon the number and quality of applications, funding for different amounts is possible, as is the offering of more than one research grant, within however, the allotted total budget stated above.
  
The Research Grant will normally begin on April 1. Research projects must be initiated by December 31 of the year awarded. Funds are to be used mainly for salary support of the investigators and research assistants and will normally be disbursed in two payments. A small amount can be devoted to project expenses.

General Conditions, Application Form and Deadlines


A letter of intent should be submitted to the Canadian Hemophilia Society by November 15, 2016. This should be a brief one to two-page letter identifying the applying researcher and organization and providing a summary description of the intended area of research.

Multidisciplinary applications are welcomed. Please note that if a multidisciplinary project is sought, you are encouraged to indicate, in the letter of intent and in the application, how the research would proceed if only one project were to be awarded.

The CHS Peer Review Committee will invite a limited number of candidates to submit a more detailed proposal by January 9, 2017 in order to make a final selection. Grants will be offered for a one-year period to begin in April 2017.
 
All completed application forms and support documents must arrive at the National Office of the Canadian Hemophilia Society on or before January 9, 2017. If the CHS receives the application after the deadline date but it is postmarked on or before the deadline date, then it is considered to have been submitted on time. The name of the winner will be announced by March 2017.

Applications must be completed and submitted electronically to the Canadian Hemophilia Society and one (1) original paper copy, including signatures, must be sent to the National Office of the Canadian Hemophilia Society:

666 Sherbrooke Street West, Suite 301, Montreal, QC H3A 1E7

Please click on the following links for General Conditions and Application Form.

Evaluation


All applications are subjected to a rigorous peer review process and will be reviewed by an independent peer review committee composed of Canadian medical and healthcare professionals and a patient representative. Applications are critiqued on scientific merit and relevance to CHS research priorities and scored in terms of significance, approach, innovation, investigator, and environment/support. The committee will rank the applications and will make recommendations to the CHS Board of Directors on funding of the proposals. The final decisions regarding awards will be made by the CHS Board of Directors. No appeals will be considered.